Super Micro targets $65B-$72B FY 2027 revenue as it guides Q1 sales of $14.5B-$15.5B (NASDAQ:SMCI)August 12, 2026
Share Facebook Twitter LinkedIn Pinterest Email Notable healthcare headlines for the week: Abbott, Medtronic, Merck and J&J in focus
Super Micro targets $65B-$72B FY 2027 revenue as it guides Q1 sales of $14.5B-$15.5B (NASDAQ:SMCI)August 12, 2026
DPC initiates FY 2026 guidance of $1.0B-$1.04B revenue and $182M-$187M adjusted EBITDA as it advances Alabama superalloy site (NYSE:DPC)August 11, 2026
By Press Room
By Press Room
By Press Room
